These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26751823)

  • 1. Type of gonadotropin during controlled ovarian stimulation affects the endocrine profile in follicular fluid and apoptosis rate in cumulus cells.
    Requena A; Cruz M; Agudo D; Pacheco A; García-Velasco JA
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():142-6. PubMed ID: 26751823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients.
    Smitz J; Andersen AN; Devroey P; Arce JC;
    Hum Reprod; 2007 Mar; 22(3):676-87. PubMed ID: 17110397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type of gonadotropin used during controlled ovarian stimulation induces differential gene expression in human cumulus cells: A randomized study.
    Cruz M; Requena A; Agudo D; García-Velasco JA
    Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():124-133. PubMed ID: 28622634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human follicle stimulating hormone versus human menopausal gonadotrophin induction: effects in mature follicle endocrinology.
    Teissier MP; Chable H; Paulhac S; Aubard Y
    Hum Reprod; 1999 Sep; 14(9):2236-41. PubMed ID: 10469686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicular fluid hormone concentrations after ovarian stimulation using gonadotropin preparations with different FSH/LH ratios. II. Comparison of hMG and recombinant FSH.
    Duijkers IJ; Willemsen WN; Hollanders HM; Hamilton CJ; Thomas CM; Vemer HM
    Int J Fertil Womens Med; 1997; 42(6):431-5. PubMed ID: 9459089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Müllerian hormone is highly expressed and secreted from cumulus granulosa cells of stimulated preovulatory immature and atretic oocytes.
    Kedem-Dickman A; Maman E; Yung Y; Yerushalmi GM; Hemi R; Hanochi M; Dor J; Hourvitz A
    Reprod Biomed Online; 2012 May; 24(5):540-6. PubMed ID: 22421733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follicular fluid hormone concentrations after ovarian stimulation using gonadotropin preparations with different FSH/LH ratios. I. Comparison of an FSH-dominant and a purified FSH preparation.
    Duijkers IJ; Willemsen WN; Hollanders HM; Hamilton CJ; Thomas CM; Vemer HM
    Int J Fertil Womens Med; 1997; 42(5):306-10. PubMed ID: 9406836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization.
    Kovacs P; Kovats T; Bernard A; Zadori J; Szmatona G; Kaali SG
    Fertil Steril; 2008 Dec; 90(6):2133-7. PubMed ID: 18177866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in gene expression of granulosa cells from women undergoing controlled ovarian hyperstimulation with either recombinant follicle-stimulating hormone or highly purified human menopausal gonadotropin.
    Grøndahl ML; Borup R; Lee YB; Myrhøj V; Meinertz H; Sørensen S
    Fertil Steril; 2009 May; 91(5):1820-30. PubMed ID: 18439596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis.
    Dahan MH; Agdi M; Shehata F; Son W; Tan SL
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():70-3. PubMed ID: 24314801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicular fluid contents of hyaluronic acid, follicle-stimulating hormone and steroids relative to the success of in vitro fertilization of human oocytes.
    Suchanek E; Simunic V; Juretic D; Grizelj V
    Fertil Steril; 1994 Aug; 62(2):347-52. PubMed ID: 8034084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulosa cells apoptosis and follicular fluid hormones: comparison of progestin-primed ovarian stimulation versus GnRH antagonist protocols.
    Li X; Zhang X; Cai J; Pang J; Sun P; Chen J; Wang M; Liang X
    Gynecol Endocrinol; 2021 Jul; 37(7):609-613. PubMed ID: 33092415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovulation induction with human menopausal gonadotropin compared to human urinary follicle-stimulating hormone results in a significant shift in follicular fluid androgen levels without discernible differences in granulosa-luteal cell function.
    Polan ML; Daniele A; Russell JB; DeCherney AH
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1284-91. PubMed ID: 3097055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
    Fornaro F; Cobellis L; Mele D; Tassou A; Badolati B; Sorrentino S; De Lucia D; Colacurci N
    Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of follicular fluid analysis in assessment of the main criteria of folliculogenesis in IVF program].
    Tsagareishvili GG
    Georgian Med News; 2005 Feb; (119):18-23. PubMed ID: 15834173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of hCG administration in cycles stimulated for in vitro fertilization: specific impact of heterogeneous follicle sizes and steroid concentrations in plasma and follicle fluid on decision procedures.
    Inaudi P; Germond M; Senn A; De Grandi P
    Gynecol Endocrinol; 1995 Sep; 9(3):201-8. PubMed ID: 8540289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures.
    Ruvolo G; Bosco L; Pane A; Morici G; Cittadini E; Roccheri MC
    Fertil Steril; 2007 Mar; 87(3):542-6. PubMed ID: 17126339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiles of cumulus cells obtained from women treated with recombinant human luteinizing hormone + recombinant human follicle-stimulating hormone or highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone alone.
    Gatta V; Tatone C; Ciriminna R; Vento M; Franchi S; d'Aurora M; Sperduti S; Cela V; Borzì P; Palermo R; Stuppia L; Artini PG
    Fertil Steril; 2013 Jun; 99(7):2000-8.e1. PubMed ID: 23472943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of bushen tiaojing recipe on the quality of the oocytes and reproductive hormones in the follicular fluid in IVF-ET patients].
    Liang Y; Du HL; Chang XF; Zhao SN; Lei LM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Aug; 34(8):911-6. PubMed ID: 25223171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of in vitro fertilization following stimulation with highly purified hMG or recombinant FSH in downregulated women of advanced reproductive age: a prospective, randomized and controlled trial.
    Ye H; Huang G; Pei L; Zeng P; Luo X
    Gynecol Endocrinol; 2012 Jul; 28(7):540-4. PubMed ID: 22390186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.